Terms: = Prostate cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1
69 results:
1. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
Colucci M; Zumerle S; Bressan S; Gianfanti F; Troiani M; Valdata A; D'Ambrosio M; Pasquini E; Varesi A; Cogo F; Mosole S; Dongilli C; Desbats MA; Contu L; Revankdar A; Chen J; Kalathur M; Perciato ML; Basilotta R; Endre L; Schauer S; Othman A; Guccini I; Saponaro M; Maraccani L; Bancaro N; Lai P; Liu L; Pernigoni N; Mele F; Merler S; Trotman LC; Guarda G; Calì B; Montopoli M; Alimonti A
Cancer Cell; 2024 Apr; 42(4):646-661.e9. PubMed ID: 38428412
[TBL] [Abstract] [Full Text] [Related]
2. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and rar-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
3. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water.
Zhang GH; Liu H; Liu MH; Liu YC; Wang JQ; Wang Y; Wang X; Xiang Z; Liu W
Comb Chem High Throughput Screen; 2024; 27(1):101-117. PubMed ID: 37170985
[TBL] [Abstract] [Full Text] [Related]
4. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
5. rarγ: The Bone of Contention for Endothelial Cells in prostate cancer Metastasis.
Bhowmick S; Bhowmick NA
Cancer Res; 2022 Sep; 82(17):2975-2976. PubMed ID: 36052494
[TBL] [Abstract] [Full Text] [Related]
6. Retinoic Acid Receptor Activation Reduces Metastatic prostate cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract] [Full Text] [Related]
7. Antagonizing rarγ Drives Necroptosis of cancer Stem Cells.
Brown G
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563205
[TBL] [Abstract] [Full Text] [Related]
8. Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience.
Boeri L; Sharma V; Kwon E; Stish BJ; Davis BJ; Karnes RJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):514-523. PubMed ID: 33268854
[TBL] [Abstract] [Full Text] [Related]
9. Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer.
Petrie K; Urban-Wójciuk Z; Sbirkov Y; Graham A; Hamann A; Brown G
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1284. PubMed ID: 32881426
[TBL] [Abstract] [Full Text] [Related]
10. The role of salvage lymph node dissection in nonmetastatic castration-resistant prostate cancer: A single center experience.
Boeri L; Sharma V; Nehra A; Kwon E; Karnes RJ
Urol Oncol; 2020 Feb; 38(2):38.e9-38.e16. PubMed ID: 31653561
[TBL] [Abstract] [Full Text] [Related]
11. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
12. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.
Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U
Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473
[TBL] [Abstract] [Full Text] [Related]
13. Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in prostate cancer.
Ishigami-Yuasa M; Ekimoto H; Kagechika H
Biol Pharm Bull; 2019; 42(3):448-452. PubMed ID: 30828077
[TBL] [Abstract] [Full Text] [Related]
14. First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH.
Griffin K; Csizmadi I; Howard LE; Pomann GM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Beebe-Dimmer J; Freedland SJ
Cancer Causes Control; 2019 Mar; 30(3):259-269. PubMed ID: 30701374
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in prostate cancer: A Meta-Analysis.
Dou M; Zhou X; Fan Z; Ding X; Li L; Wang S; Xue W; Wang H; Suo Z; Deng X
Cell Physiol Biochem; 2018; 45(6):2497-2505. PubMed ID: 29554659
[TBL] [Abstract] [Full Text] [Related]
16. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other cancers.
Maatough A; Whitfield GK; Brook L; Hsieh D; Palade P; Hsieh JC
J Cell Biochem; 2018 Jan; 119(1):69-80. PubMed ID: 28543886
[TBL] [Abstract] [Full Text] [Related]
17. Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases.
Napoli JL
Pharmacol Ther; 2017 May; 173():19-33. PubMed ID: 28132904
[TBL] [Abstract] [Full Text] [Related]
18. Comparing conventional laparoscopic to robotic-assisted extended pelvic lymph node dissection in men with intermediate and high-risk prostate cancer: a matched-pair analysis.
Albisinni S; Aoun F; LE Dinh D; Zanaty M; Hawaux E; Peltier A; VAN Velthoven R
Minerva Urol Nefrol; 2017 Feb; 69(1):101-107. PubMed ID: 28009151
[TBL] [Abstract] [Full Text] [Related]
19. Ten-year experience of robot-assisted radical prostatectomy: the road from cherry-picking to standard procedure.
Schiffmann J; Haese A; Boehm K; Salomon G; Steuber T; Heinzer H; Huland H; Graefen M; Karakiewicz PI
Minerva Urol Nefrol; 2017 Feb; 69(1):69-75. PubMed ID: 28009147
[TBL] [Abstract] [Full Text] [Related]
20. Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.
Eskra JN; Kuiper JW; Walden PD; Bosland MC; Özten N
Eur J Cancer Prev; 2017 Jan; 26(1):71-77. PubMed ID: 26886237
[TBL] [Abstract] [Full Text] [Related]
[Next]
